Newsletter Signup | Join Community
Checkpoint Inhibitor Immunotherapy Combinations Improve Survival in Advanced Kidney Cancer – Should be the New Standard
First-Line Inlyta Active in Metastatic Kidney Cancer
The kinase inhibitor Cabometyx™ is effective treatment as initial and or second line treatment of advanced kidney cancer
Opdivo® approved by US FDA for treatment of advanced renal cell cancer.
Inlyta Approved for Advanced Kidney Cancer.
Oral Precision Cancer Medicine Votrient Improves Progression-free Survival in Advanced Kidney Cancer.
Long-Term Survival of Patients with Renal Cell Cancer After High-Dose Continuous Infusion of Interleukin-2
Updated Results Confirm Survival Benefit of Nexavar® in Renal Cell Carcinoma
Dr. Janice Dutcher (NY), Dr. Keith Flaherty (Penn) Dr. David I. Quinn (USC) discuss kidney cancer.
Bevacizumab Delays Cancer Progression in Metastatic Renal Cell Cancer
Has anyone had their kidney cancer removed by laproscope? Doctor says recovery will be much quicker.…